Table 1.
Clinical characteristics of patients with HPIV infections [n (%)]
| Parameters | No. of sample | HPIV | HPIV-1 | HPIV-2 | HPIV-3 | HPIV-4 |
|---|---|---|---|---|---|---|
| Year | ||||||
| 2011 | 772 | 70 (9·07) | 28 (40·00) | 8 (11·43) | 27 (38·57) | 7 (10·00) |
| 2012 | 850 | 38 (4·47) | 11 (28·95) | 5 (13·16) | 17 (44·74) | 5 (13·16) |
| 2013 | 1052 | 37 (3·52) | 2 (5·40) | 15 (40·54) | 8 (21·62) | 12 (32·43) |
| 2014 | 1304 | 72 (5·52) | 15 (20·83) | 5 (6·94) | 36 (50·00) | 16 (22·22) |
| Total | 3978 | 217 (5·46) | 56 (25·81) | 33 (15·21) | 88 (40·55) | 40 (18·43) |
| Gender | ||||||
| Male | 2214 | 125 (5·65) | 34 (27·20) | 19 (15·2) | 57 (45·60) | 15 (12·00) |
| Female | 1764 | 92 (5·22) | 22 (23·91) | 14 (15·22) | 31 (33·69) | 25 (27·17) |
| Age group (Years) | ||||||
| 0–5 | 753 | 67 (7·75) | 8 (11·94) | 12 (17·91) | 37 (55·22) | 10 (14·93) |
| 6–15 | 519 | 21 (4·05) | 5 (23·81) | 4 (19·05) | 7 (33·33) | 5 (23·81) |
| 16–25 | 615 | 26 (4·23) | 12 (46·15) | 2 (7·67) | 7 (26·92) | 5 (19·23) |
| 26–59 | 1413 | 66 (4·67) | 22 (33·333) | 6 (9·09) | 22 (33·33) | 16 (24·24) |
| ≥60 | 678 | 37 (5·46) | 9 (24·32) | 9 (24·32) | 15 (40·54) | 4 (10·81) |
| Infection sites | ||||||
| URTIs* | 2171 | 127 (5·85) | 33 (25·98) | 21 (16·54) | 42 (33·07) | 30 (23·62) |
| LRTIs** | 1807 | 90 (4·98) | 23 (25·56) | 12 (13·33) | 46 (51·11) | 10 (11·11) |
*
Upper respiratory tract infection.
**
Lower respiratory tract infection.